Ramona Reichenbach
Head Managed Access & Medical Policy Novartis AG
Ramona Reichenbach is Head of Managed Access & Medical Policy at Novartis, where she leads enterprise-wide strategy, governance, and global standards for Managed Access and Post-Trial Access programmes. With over 20 years in global drug development, she specialises in designing scalable frameworks, aligning cross-functional stakeholders, and shaping policy to enable equitable access across diverse healthcare systems. A recognised thought leader in the field, Ramona actively contributes to industry collaboration, publications, and global forums to advance harmonisation and improve how access programmes are delivered worldwide.
Seminars
Tuesday 20th October 2026
Responding to New FDA Expanded Access Guidance & MFN Pricing: What Has Changed & What Access Teams Must Do Now
2:00 pm
- Interpreting recent FDA expanded access guidance on broader eligibility, sponsor responsibility, and proactive access planning – and what this changes in practice
- Understanding how MFN pricing dynamics are extending time to launch and increasing reliance on early and managed access pathways
- Aligning expanded access planning with pricing driven launch uncertainty without creating open ended access commitments
- Evaluating whether existing access governance, resourcing, and supply models are fit for increased regulatory expectation and prolonged pre commercial access
Wednesday 21st October 2026
ia4ma: Achieving Global Impact Through a Non-Profit, Independent Association
1:45 pm
- Establishing a shared vision and foundation for Managed Access, aligning on ethical principles and industry standards to reduce fragmentation and enable sustainable global pathways
- Delivering value for patients, industry and stakeholders by accelerating equitable access, improving operational efficiency, and enabling meaningful peer and regulatory exchange
- Driving system level impact beyond individual programs by shaping policy, fostering multi stakeholder collaboration, and strengthening global trust in Managed Access
